Robert Fulton

Assistant Professor

Washington University in St. Louis
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Single-cell DNA sequencing offers a powerful means of studying somatic mosaicism but requires careful analysis to mitigate DNA amplification-related artifacts. We performed primary template-directed amplification (PTA) and sequencing of 102 nuclei from postmortem lung and colon tissues of a 74-year-old male. Single-cell mutation burdens and spectra were validated by duplex sequencing and revealed heterogeneity across organs and cells, including signatures of APOBEC activity and tobacco exposure. Cells from both tissues exhibited chromosomal aneuploidies, loss of chromosome Y, and chromosomal rearrangements including rearrangements of the T-cell receptor loci indicative of T-cells. Shared embryonic mutations between cells enabled reconstruction of cellular ancestries from the zygote, which were validated by bulk sequencing. Collectively, we demonstrate a comprehensive approach for single-cell genomics that yields an expansive view of diverse somatic mutation types from development through aging across diverse tissues—insights that are obscured in bulk sequencing and only partially captured by other single-cell methods.

Year:

2025

Mosaic mutations in normal tissues occur at low variant allele fractions (VAFs), complicating detection. To benchmark strategies, the SMaHT Network created a cell-line mixture (1:49) and produced ultra-deep whole-genome sequencing using short and long reads (five centers, 180–500× each). We assembled a reference of 44,008 mosaic SNVs and 2,059 Indels, cross-validation between platforms to expose limits of short-read analysis. We also partitioned the genome by mappability to examine the impact of genomic context, added a negative reference set, and accounted for culture-derived mutations. When seven institutions applied eleven algorithms to mixture data, call sets were largely discordant across tools and replicates, partly reflecting stochastic presence of low-VAF mutations in biological replicants. For >2% VAF SNVs, sensitivity and precision approached ∼80% at ≥300×, with little gain from additional sequencing. This work provides a comprehensive framework for reliable detection of low-VAF mutations in non-cancer tissues and a valuable resource for the community.

Year:

2025

Regulating Hippo. A, Diagram of pathways that regulate Hippo signaling. Identified SMGs are shown in red; genes mutated in at least one non-hypermutated sample are shown in yellow; genes only mutated in the hypermutated sample (HL-513) are shown in orange. The gene mutation frequency across the cohort is shown as a percent. The pathways labeled in green indicate larger pathways not shown in this diagram. B, The total number and type of mutation observed are shown in the inset bar chart. C, Lolliplot of CDH5 ; mutations identified in the current study are shown on the top and COSMIC mutations found in lymphoid tissue on the bottom. D, Lolliplot of mutations identified at GNA13 ; mutations identified in the current study are shown on the top and COSMIC mutations found in lymphoid tissue on the bottom.

Year:

2025

The malignant Hodgkin and Reed Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL) are scarce in affected lymph nodes, creating a challenge to detect driver somatic mutations. As an alternative to cell purification techniques, we hypothesized that ultra-deep exome sequencing would allow genomic study of HRS cells, thereby streamlining analysis and avoiding technical pitfalls. To test this, 31 cHL tumor/normal pairs were exome sequenced to approximately 1,000× median depth of coverage. An orthogonal error-corrected sequencing approach verified >95% of the discovered mutations. We identified mutations in genes novel to cHL including: CDH5 and PCDH7, novel stop gain mutations in IL4R , and a novel pattern of recurrent mutations in pathways regulating Hippo signaling. As a further application of our exome sequencing, we attempted to identify expressed somatic single-nucleotide variants (SNV) in single-nuclei RNA sequencing (snRNA-seq) data generated from a patient in our cohort. Our snRNA analysis identified a clear cluster of cells containing a somatic SNV identified in our deep exome data. This cluster has differentially expressed genes that are consistent with genes known to be dysregulated in HRS cells (e.g., PIM1 and PIM3 ). The cluster also contains cells with an expanded B-cell clonotype further supporting a malignant phenotype. This study provides proof-of-principle that ultra-deep exome sequencing can be utilized to identify recurrent mutations in HRS cells and demonstrates the feasibility of snRNA-seq in the context of cHL. These studies provide the foundation for the further analysis of genomic variants in large cohorts of patients with cHL. Significance: Our data demonstrate the utility of ultra-deep exome sequencing in uncovering somatic variants in Hodgkin lymphoma, creating new opportunities to define the genes that are recurrently mutated in this disease. We also show for the first time the successful application of snRNA-seq in Hodgkin lymphoma and describe the expression profile of a putative cluster of HRS cells in a single patient.

Year:

2025

Collaborators (27)

Yoo-Jin Ha

Assistant Professor

Hanyang University

SOUTH KOREA
View details

Andrew Stergachis

University of Washington

UNITED STATES
View details

Todd A. Fehniger

Professor

Washington University School of Medicine

UNITED STATES
View details

Obi Griffith

Professor

Washington University in St. Louis

UNITED STATES
View details

Kilannin Krysiak

Associate Professor

Washington University in St. Louis

UNITED STATES
View details

Nancy Bartlett

Koman Professor of Medical Oncology in Medicine

Washington University in St. Louis

UNITED STATES
View details

James Bennett

Principal Investigator

Seattle Children's Research Institute

UNITED STATES
View details

Peter Park

Harvard University

UNITED STATES
View details

David A. Russler-Germain

Washington University School of Medicine

UNITED STATES
View details

Ting Wang

Washington University School of Medicine

UNITED STATES
View details

Alexej Abyzov

Associate Professor of Biomedical Informatics

Mayo Clinic

UNITED STATES
View details

Abhiram Natu

Yale University

UNITED STATES
View details

Zachary Skidmore

Senior Scientist

Washington University in St. Louis

UNITED STATES
View details

Zhi Yu

Broad Institute

UNITED STATES
View details

Julia Markowski

University of Potsdam

GERMANY
View details

harshavardhan doddapaneni

Associate Professor

Baylor College of Medicine

UNITED STATES
View details

Eric J. Duncavage

Professor/Director of Molecular Oncology

Washington University School of Medicine

UNITED STATES
View details

Malachi Griffith

Professor

Washington University in St. Louis

UNITED STATES
View details

Tim Coorens

Research Group Leader

European Bioinformatics Institute

UNITED KINGDOM
View details

Christopher Miller

Associate Professor

Washington University in St. Louis

UNITED STATES
View details

Felicia Gomez

Assistant Professor (tenure track)

Washington University in St. Louis

UNITED STATES
View details

JI WON OH

Assistant Professor

Yonsei University College of Medicine

SOUTH KOREA
View details

Mee Sook Jun

Research professor

Kyungpook National University

SOUTH KOREA
View details

Christopher Walsh

Chief

Boston Children's Hospital

UNITED STATES
View details

Daofeng Li

Assistant Professor

Washington University in St. Louis

UNITED STATES
View details

Neha Mehta-Shah

Washington University School of Medicine

UNITED STATES
View details

Flora Vaccarino

Professor

Yale University

UNITED STATES
View details